ArticleDrug design, development and therapy2026
Real-World Outcomes of Aflibercept 2 mg Using a Treat-and-Extend Protocol for Neovascular Age-Related Macular Degeneration: A 24-Month Retrospective Study in a Chinese Population.
Yuanyuan Qi et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.